Table III.
Clinicopathological characteristics and the genotypes of rs2292832 in nasopharyngeal carcinoma patients.
| rs2292832
|
|||||
|---|---|---|---|---|---|
| Parameters | CC | CT | TT | P-value | P-value (CC vs. TT) |
| Age (years) | |||||
| <45 | 8 (10.7) | 28 (37.3) | 39 (52.0) | 0.121 | 0.099 |
| ≥45 | 14 (16.9) | 39 (47.0) | 30 (36.1) | ||
| Gender | |||||
| Male | 16 (14.0) | 50 (43.9) | 48 (42.1) | 0.803 | 0.777 |
| Female | 6 (13.6) | 17 (38.6) | 21 (47.7) | ||
| T stage | |||||
| T1–T2 | 7 (13.7) | 25 (49.0) | 19 (37.3) | 0.386 | 0.757 |
| T3–T4 | 15 (14.9) | 38 (37.6) | 48 (47.5) | ||
| N stage | |||||
| N0 | 3 (33.3) | 4 (44.4) | 2 (22.2) | 0.182 | 0.094 |
| N1-N2-N3 | 19 (13.3) | 59 (41.3) | 65 (45.5) | ||
| Metastasis | |||||
| No | 21 (15.1) | 57 (41.0) | 61 (43.9) | 0.884 | 1.000 |
| Yes | 1 (10.0) | 4 (40.0) | 5 (50.0) | ||
| Clinical stage | |||||
| I–II | 4 (44.4) | 3 (33.3) | 2 (22.2) | 0.026 | 0.030 |
| III–IV | 18 (12.4) | 61 (42.1) | 66 (45.5) | ||